tradingkey.logo

BUZZ-Australia's 4DMedical soars as US FDA clears lung diagnostic tool

ReutersJan 7, 2025 4:14 AM

** Shares of Australia's 4DMedical 4DX.AX rise as much as 14.7% to A$0.545, hitting their highest since early December 2024

** Medical technology-focussed firm says it has received clearance from the U.S. Food and Drug Administration for its IQ-UIP™ product

** The product is an advanced AI-driven lung diagnostic tool designed for the diagnosis of usual interstitial pneumonia

** Stock fell 32.9% in 2024

(Reporting by Jasmeen Ara Shaikh in Bengaluru)

((Jasmeenaraislam.shaikh@thomsonreuters.com))

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI